The review found no eligible studies for this question.
It is very uncertain whether coasting changes clinical pregnancy rate compared with cabergoline (very low certainty).
The review found no eligible studies for this question.
Coasting showed no clear difference in clinical pregnancy compared with no coasting (low certainty).
Coasting may leads to lower multiple pregnancy compared with no coasting (low certainty).
It is very uncertain whether coasting changes clinical Pregnancy compared with early unilateral follicular aspiration (very low certainty).
The review found no eligible studies for this question.
Mannitol showed no clear difference in pregnancy rate compared with placebo / no treatment (low certainty).
Human albumin probably leads to lower pregnancy rate compared with placebo or no treatment (moderate certainty).
It is very uncertain whether HES changes pregnancy rate compared with placebo or no treatment (very low certainty).
It is very uncertain whether metformin changes clinical pregnancy rate per woman ‐ short protocol GnRH‐antagonist compared with placebo or no treatment (very low certainty).
Metformin may leads to higher clinical pregnancy rate per womanaParticipants with BMI < 30 kg/m2… compared with clomiphene citrate (low certainty).
Metformin may leads to lower clinical pregnancy rate per woman aParticipants with BMI ≥ 30 kg/m2 compared with clomiphene citrate (low certainty).
Metformin combined with clomiphene citrate probably leads to higher clinical pregnancy rate per woman compared with clomiphene citrate alone (moderate certainty).
ORT‐based algorithm showed no clear difference in live birth or ongoing pregnancy compared with standard starting dose of FSH (low certainty).
ORT‐based algorithm showed no clear difference in clinical pregnancy compared with standard starting dose of FSH (low certainty).
It is very uncertain whether intrauterine injection of autologous platelet‐rich plasma changes live birth (or ongoing pregnancy) compared with no intervention (very low certainty).
Intrauterine infusion/injection of autologous platelet‐rich plasma may leads to higher adverse events: preterm delivery compared with no intervention or placebo (low certainty).
It is very uncertain whether intrauterine infusion of autologous platelet‐rich plasma changes live birth (or ongoing pregnancy compared with intrauterine infusion of granulocyte colony‐stimulating factor (very low certainty).
It is very uncertain whether intrauterine infusion of autologous platelet‐rich plasma changes clinical pregnancy compared with intrauterine infusion of granulocyte colony‐stimulating factor (very low certainty).